United Asset Strategies’s ResMed RMD Stock Holding History

United Asset Strategies’s Portfolio RMD Stock Details RMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$3.24M	Buy	16,616 +607	+4%	+$126K	0.23%	82
2026 Q1	$3.59M	Buy	16,009 +6,367	+66%	+$1.59M	0.29%	72
2025 Q4	$2.32M	Buy	9,642 +415	+4%	+$106K	0.18%	96
2025 Q3	$2.53M	Sell	9,227 -90	-1%	-$24.6K	0.2%	83
2025 Q2	$2.4M	Buy	+9,317	New	+$2.22M	0.21%	88
2022 Q3	–	Sell	-5,605	Closed	-$1.18M	–	225
2022 Q2	$1.18M	Buy	+5,605	New	+$1.19M	0.17%	109

Other funds holding RMD

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return

Nordea Investment Management Stockholm, Sweden $123B AUM 38.85% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

United Asset Strategies's RMD Position: Q2 2026 in Review

United Asset Strategies increased its ResMed (RMD) stake by 3.8% in Q2 2026, buying an estimated $126K and bringing the position to 16,616 shares worth $3.24M. The position accounts for 0.23% of the portfolio, ranked #82.

United Asset Strategies first reported a position in RMD in Q2 2022 and has held it in 6 quarters since. The position peaked at $3.59M in Q1 2026. 579 funds tracked by Wall St. Rank hold RMD as of Q2 2026.

United Asset Strategies held 16,616 shares of ResMed worth $3.24M as of Q2 2026.
United Asset Strategies bought 607 ResMed shares in Q2 2026, an estimated $126K.
ResMed made up 0.23% of United Asset Strategies's portfolio in Q2 2026, its #82 holding.
United Asset Strategies first reported a position in ResMed in Q2 2022 and has held it in 6 quarters since.
United Asset Strategies's ResMed position peaked at $3.59M in Q1 2026.
579 funds tracked by Wall St. Rank held ResMed as of Q2 2026.

Based on United Asset Strategies's 13F filing for Q2 2026, filed 13 Jul 2026.